Stay updated on Nivolumab in Advanced Colon Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Advanced Colon Cancer Clinical Trial page.

Latest updates to the Nivolumab in Advanced Colon Cancer Clinical Trial page
- Check6 days agoChange DetectedMinor revision update: Revision v3.3.2 replaces v3.3.1 on the page. No changes to study content, eligibility criteria, or primary endpoints are visible.SummaryDifference0.0%

- Check13 days agoChange DetectedThe Publications section now notes that PubMed entries are automatically populated and may not all pertain to the study, and the page shows Revision: v3.3.1.SummaryDifference0.1%

- Check21 days agoChange DetectedAdded Results First Posted (Estimated) and Last Update Posted (Estimated) entries to the Study Record Dates, and removed the plain Results First Posted and Last Update Posted entries.SummaryDifference0.4%

- Check28 days agoChange DetectedResults for the study were posted (2025-11-06). Madrid, Spain locations were added, and the primary and secondary outcome definitions and time frames (ORR by investigator and by IRC) were updated to reflect the study design.SummaryDifference2%

- Check35 days agoChange DetectedNo significant changes observed; core content such as study title, summary, eligibility criteria, and locations remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check64 days agoChange Detected- Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.SummaryDifference4%

Stay in the know with updates to Nivolumab in Advanced Colon Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Advanced Colon Cancer Clinical Trial page.